Aliases & Classifications for Arteriosclerosis

MalaCards integrated aliases for Arteriosclerosis:

Name: Arteriosclerosis 12 52 42 14 69
Arteriosclerotic Vascular Disease Nos 12
Arteriosclerotic Vascular Disease 12
Arteriosclerosis Nos 12

Classifications:



External Ids:

Disease Ontology 12 DOID:2349
ICD10 33 I70
MeSH 42 D001161
NCIt 47 C34398
UMLS 69 C0003850

Summaries for Arteriosclerosis

Disease Ontology : 12 An artery disease that is characterized by a thickening and hardening of arterial walls in the arteries.

MalaCards based summary : Arteriosclerosis, also known as arteriosclerotic vascular disease nos, is related to angina pectoris and pyelonephritis, and has symptoms including angina pectoris An important gene associated with Arteriosclerosis is APOB (Apolipoprotein B), and among its related pathways/superpathways are Degradation of the extracellular matrix and Fluid shear stress and atherosclerosis. The drugs Aspirin and Cilostazol have been mentioned in the context of this disorder. Affiliated tissues include heart, endothelial and testes, and related phenotypes are Decreased free cholesterol and cardiovascular system

Wikipedia : 72 Arteriosclerosis is the thickening, hardening and loss of elasticity of the walls of arteries. This... more...

Related Diseases for Arteriosclerosis

Diseases related to Arteriosclerosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 207)
id Related Disease Score Top Affiliating Genes
1 angina pectoris 30.6 APOA1 APOB CRP SERPINE1 VCAM1
2 pyelonephritis 30.1 CRP EDN1 HMOX1 ICAM1
3 myocardial infarction 28.9 ADIPOQ APOA1 APOB APOE CCL2 COG2
4 peripheral artery disease 28.5 ADIPOQ APOA1 APOB APOE CCL2 COG2
5 arteriosclerosis obliterans 12.3
6 cerebral arteriosclerosis 12.3
7 intracranial arteriosclerosis 12.0
8 monckeberg arteriosclerosis 11.9
9 atherosclerosis 11.2
10 coronary artery disease 11.1
11 uterine inflammatory disease 10.9 EDN1 SERPINE1
12 spinal cord infarction 10.9
13 achard thiers syndrome 10.9 ADIPOQ PPARG
14 arterial calcification of infancy 10.9
15 corpus callosum agenesis of blepharophimosis robin type 10.9 ADIPOQ CCL2 VCAM1
16 otospondylomegaepiphyseal dysplasia 10.9 APOA1 APOB SERPINE1
17 adams-oliver syndrome 5 10.9 CRP ELN SPP1
18 inferolateral myocardial infarct 10.9 ICAM1 SERPINE1 VCAM1
19 neuroaxonal dystrophy 10.8 CCL2 ICAM1 SERPINE1
20 cytomegalovirus retinitis 10.8 CCL2 ICAM1
21 craniopharyngioma 10.8 ICAM1 SERPINE1 VCAM1
22 oppositional defiant disorder 10.8 ICAM1 SERPINE1 VCAM1
23 hypomagnesemia 3, renal 10.8 ADIPOQ PPARG SERPINE1
24 autoimmune polyglandular syndrome type 3 10.8 PPARG SPP1 VCAM1
25 louping ill 10.8 CCL2 CRP ICAM1
26 emphysema, congenital lobar 10.8 CRP PON1 VCAM1
27 craniosynostosis 7 10.8 CRP ELN SPP1
28 angiosarcoma 10.8 ELN HGF
29 xk aprosencephaly 10.8 APOB APOE
30 arthritis 10.8 APOE PON1 SPP1
31 bardet-biedl syndrome 8 10.8 CRP ELN HMOX1
32 schimke immunoosseous dysplasia 10.8
33 werner syndrome 10.8
34 preeclampsia/eclampsia 1 10.8 EDN1 SERPINE1 VCAM1
35 perrault syndrome 10.8 CCL2 HGF SERPINE1
36 cerebral atherosclerosis 10.8
37 retinopathy, arteriosclerotic 10.8
38 hypercholesterolemia, due to ligand-defective apo b 10.8 APOB APOE
39 psychosexual disorder 10.8 CRP ICAM1 SERPINE1 VCAM1
40 compensatory emphysema 10.7 CCL2 CRP HSPD1
41 idiopathic juxtafoveal retinal telangiectasia 10.7 ADIPOQ EDN1 PPARG
42 uterine corpus sarcoma 10.7 ADIPOQ HGF ICAM1 VCAM1
43 scabies 10.7 CCL2 CRP ICAM1
44 benign secondary hypertension 10.7 CCL2 ICAM1 SERPINE1 VCAM1
45 citrullinemia, adult-onset type ii 10.7 ICAM1 PON1 SERPINE1 VCAM1
46 acute chest syndrome 10.7 CCL2 CRP ICAM1
47 focal dystonia 10.7 APOB CCL2 CRP VCAM1
48 migraine with or without aura 1 10.7 APOA1 APOB APOE
49 familial osteochondritis dissecans 10.7 APOA1 APOE
50 lymphomatous thyroiditis 10.7 ICAM1 VCAM1

Graphical network of the top 20 diseases related to Arteriosclerosis:



Diseases related to Arteriosclerosis

Symptoms & Phenotypes for Arteriosclerosis

UMLS symptoms related to Arteriosclerosis:


angina pectoris

GenomeRNAi Phenotypes related to Arteriosclerosis according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased free cholesterol GR00340-A-2 8.92 APOA1 APOB APOE HMGCR

MGI Mouse Phenotypes related to Arteriosclerosis:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.33 CRP EDN1 HGF HMOX1 ICAM1 MGP
2 growth/size/body region MP:0005378 10.28 APOB APOE COG2 EDN1 HGF HMGCR
3 homeostasis/metabolism MP:0005376 10.27 ADIPOQ APOA1 APOB APOE COG2 CRP
4 cellular MP:0005384 10.21 ADIPOQ APOA1 APOB APOE HGF HMOX1
5 immune system MP:0005387 10.06 APOE CCL2 CRP HMOX1 ICAM1 PPARG
6 mortality/aging MP:0010768 10 ICAM1 MGP PPARG SERPINE1 SPP1 VCAM1
7 liver/biliary system MP:0005370 9.96 ADIPOQ APOA1 APOB APOE HGF HMGCR
8 muscle MP:0005369 9.65 ADIPOQ APOB APOE EDN1 HMOX1 HSPD1
9 renal/urinary system MP:0005367 9.23 ADIPOQ APOE EDN1 HMOX1 MGP PPARG

Drugs & Therapeutics for Arteriosclerosis

Drugs for Arteriosclerosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 870)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-78-2 2244
2
Cilostazol Approved Phase 4,Phase 3,Phase 2,Phase 1 73963-72-1 2754
3
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3 50-28-2 5757
4
Progesterone Approved, Vet_approved Phase 4,Phase 3,Phase 2 57-83-0 5994
5
Daclizumab Approved, Investigational Phase 4 152923-56-3
6
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1 159351-69-6 6442177
7
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
8
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 53123-88-9 5284616 6436030 46835353
9
Methyltestosterone Approved Phase 4,Phase 3,Phase 2 58-18-4 6010
10
Testosterone Approved, Investigational Phase 4,Phase 3,Phase 2 58-22-0 6013
11
Pravastatin Approved Phase 4,Phase 3,Phase 2,Phase 1 81093-37-0 54687
12
Benzocaine Approved Phase 4,Phase 3,Phase 2,Phase 1 1994-09-7, 94-09-7 2337
13
Enalapril Approved, Vet_approved Phase 4,Phase 3,Phase 2 75847-73-3 5362032 40466924
14
Enalaprilat Approved Phase 4,Phase 3,Phase 2 76420-72-9 6917719
15
Rimonabant Approved, Investigational Phase 4,Phase 3 168273-06-1, 158681-13-1 104850
16
Simvastatin Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 79902-63-9 54454
17
Paclitaxel Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 33069-62-4 36314
18
Fluvastatin Approved Phase 4,Phase 3 93957-54-1 1548972
19
Adenosine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 58-61-7 60961
20
Ticagrelor Approved Phase 4,Phase 2,Phase 3,Phase 1 274693-27-5 9871419
21
Ticlopidine Approved Phase 4,Phase 3,Phase 2,Phase 1 55142-85-3 5472
22
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 9005-49-6 772 46507594
23
Tirofiban Approved Phase 4,Phase 3,Phase 1 144494-65-5 60947
24
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3 73590-58-6 4594
25
Pantoprazole Approved Phase 4,Phase 3 102625-70-7 4679
26
Chromium Approved Phase 4,Phase 3,Phase 2,Phase 1 7440-47-3 27668
27
Metoprolol Approved, Investigational Phase 4,Phase 3,Phase 1 37350-58-6, 51384-51-1 4171
28
Amlodipine Approved Phase 4,Phase 3 88150-42-9 2162
29
Ranolazine Approved, Investigational Phase 4,Phase 2,Phase 3 142387-99-3, 95635-55-5 56959
30
Ezetimibe Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 163222-33-1 150311
31
Chlorhexidine Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 55-56-1 9552079 2713
32
Esmolol Approved Phase 4,Phase 3 103598-03-4, 81147-92-4 59768
33
Nicardipine Approved Phase 4,Early Phase 1 55985-32-5 4474
34
Bivalirudin Approved, Investigational Phase 4,Phase 3,Phase 2 128270-60-0 16129704
35
Dipyridamole Approved Phase 4,Phase 3,Phase 2,Phase 1 58-32-2 3108
36
Regadenoson Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 313348-27-5 219024
37
Pioglitazone Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 111025-46-8 4829
38
Zinc Approved Phase 4,Phase 3,Phase 1 7440-66-6 32051 23994
39
Bupivacaine Approved, Investigational Phase 4,Phase 3,Phase 2 2180-92-9, 38396-39-3 2474
40
Clonidine Approved Phase 4 4205-90-7 2803
41
Levobupivacaine Approved Phase 4 27262-47-1 92253
42
Morphine Approved, Investigational Phase 4 57-27-2 5288826
43
Carvedilol Approved, Investigational Phase 4,Phase 3 72956-09-3 2585
44
Valsartan Approved, Investigational Phase 4,Phase 3,Phase 2 137862-53-4 60846
45
Citalopram Approved Phase 4,Phase 3 59729-33-8 2771
46
Olmesartan Approved, Investigational Phase 4,Phase 3 144689-24-7, 144689-63-4 158781 130881
47
Metformin Approved Phase 4,Phase 2,Phase 3 657-24-9 14219 4091
48
Coal tar Approved Phase 4,Phase 1,Phase 2 8007-45-2
49
Nicorandil Approved Phase 4 65141-46-0 47528
50
Ethanol Approved Phase 4,Early Phase 1 64-17-5 702

Interventional clinical trials:

(show top 50) (show all 5368)

id Name Status NCT ID Phase Drugs
1 Sufficient Treatment of Peripheral Intervention by Cilostazol Unknown status NCT00912756 Phase 4 cilostazol
2 Kronos Early Estrogen Prevention Study (KEEPS) Unknown status NCT00154180 Phase 4 Conjugated equine estrogens 0.45 mg/day;Transdermal estradiol, 50 mcg/day;Micronized progesterone, 200 mg/day x 12 d/month;CEE , progesterone, estradiol patch or placebo for each;CEE, progesterone, transdermal patch or the placebo
3 Study to Investigate the Effect of Heart Rate Reduction With Ivabradine on Vascular Elastic Properties and Endothelial Function in Patients With Stable Coronary Heart Disease Unknown status NCT01768585 Phase 4 Ivabradine;Placebo
4 The Low HDL On Six Weeks Statin Therapy (LOW) Study Unknown status NCT00238004 Phase 4 Nicotinic acid
5 Effect of Short Term Atorvastatin Treatment,80mg/Day on Early Regression of Carotid Artery Atherosclerotic Lesions Unknown status NCT00640744 Phase 4 Atorvastatin
6 Fibrosis in Renal Allografts Unknown status NCT00493194 Phase 4 sirolimus;cyclosporine;daclizumab
7 Testosterone Therapy on Angina Threshold and Atheroma in Patients With Chronic Stable Angina Unknown status NCT00131183 Phase 4 Nebido
8 Fractional Flow Reserve Versus Angiography Randomization for Graft Optimization Trial Unknown status NCT02477371 Phase 4
9 The Effects of Pravastatin and Rosuvastatin on Coronary Plaques in Patients With Stable Angina Pectoris Unknown status NCT01325818 Phase 4 pravastatin, rosuvastatin
10 Does Rosuvastatin Delay Progression of Atherosclerosis in HIV Unknown status NCT01813357 Phase 4 Rosuvastatin
11 Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases. Unknown status NCT00734123 Phase 4 Simvastatin or Atorvastatin;Enalapril;Aspirin or clopidogrel;Rimonabant
12 Homocysteine Lowering and Atherosclerosis Reduction Trial (HART) Unknown status NCT00217178 Phase 4 Vitamins: Folic acid, B6, B12
13 Vitamin K2 and Vessel Calcification in Chronic Kidney Disease Patients Unknown status NCT01101698 Phase 4 Vitamin K2+10μg cholecalciferol;Vitamin D
14 Paclitaxel Eluting Stent or Exercise for Thigh Atherosclerosis Unknown status NCT02033135 Phase 4
15 Efficacy of Self-Expanding Nitinol S.M.A.R.T CONTROL Stent Versus Life Stent For The Atherosclerotic Femoro-Popliteal Arterial Disease Unknown status NCT01653600 Phase 4
16 The Effect of Vitamin A on Atherosclerosis Unknown status NCT01414972 Phase 4 Vitamin A;placebo
17 The Study of the Effects of Vitamin A on Immune System in Patients With Atherosclerosis Unknown status NCT00963222 Phase 4 vitamin A;placebo
18 The Effect of Dates on Plasma Lipids, Oxidative Stress and the Atherogenicity of Serum in Healthy Adults Unknown status NCT00750789 Phase 4
19 The Effect of a Natural Polyphenolic Extract From Pomegrnate (POMX) on the Development of Atherosclerosis in Diabetic Patients Unknown status NCT00470808 Phase 4 POMx
20 ATHERO: Advanced Technology Halting Early Re-Stenosis and Occlusion Unknown status NCT00407940 Phase 4
21 Fluvastatin AmelIorates aTHerosclerosis Study Unknown status NCT01681199 Phase 4 Fluvastatin extended release tablet
22 The ABC Trial Does All-Blood Cardioplegia Prevent Blood Transfusion in Cardiac Surgery? A Single Centre Pilot Study Unknown status NCT01623193 Phase 4
23 Endothelial Dysfunction in Subjects With History of Premature Coronary Artery Disease Unknown status NCT00917527 Phase 4 Atorvastatin
24 Relation Among Shear Stress Distribution, Stent Design, and Subsequent Vessel Healing After Drug-eluting Stent Implantation (SHEAR DES) Unknown status NCT01942044 Phase 4
25 Effects of REnal Denervation for Resistant Hypertension on Exercise Diastolic Function and Regression of Atherosclerosis and the Evaluation of NEW Methods Predicting A successfuL Renal Sympathetic Denervation (RENEWAL-EXERCISE, -REGRESS, and -PREDICT Tria Unknown status NCT01918111 Phase 4 adenosine infusion treatment
26 Danshen Dropping Pill for Coronary Heart Disease Heart and Artery Structure and Function Unknown status NCT01825759 Phase 4 danshen dripping pill
27 Intracoronary Stenting and Antithrombotic Regimen: ADjusting Antiplatelet Treatment in PatienTs Based on Platelet Function Testing Unknown status NCT01456364 Phase 4 Ticagrelor;Prasugrel
28 Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - SAfety & EffectiveneSS of Drug-ElUting Stents & Anti-platelet REgimen Unknown status NCT01267734 Phase 4 Triple anti-platelet therapy (TAT);Double-dose clopidogrel anti-platelet therapy (DDAT)
29 Test of Long-Term Safety and Efficacy of Sirolimus-Permanent-Polymer Eluting Stent (Cypher)- and Sirolimus-Polymer-free Eluting Stents (PPS/PFS) Assessed by Optical Coherence Tomography Unknown status NCT01260558 Phase 4
30 Test Safety and Efficacy of Zotarolimus- and Everolimus-Eluting Stents (ZES/EES) Assessed by Optical Coherence Tomography Unknown status NCT01230723 Phase 4
31 Paclitaxel Eluting Balloon and Conventional Balloon for In-Stent Restenosis of the Superficial Femoral Artery Unknown status NCT01083394 Phase 4
32 Test Efficacy of Biodegradable and Permanent Limus-Eluting Stents Unknown status NCT01068106 Phase 4
33 Efficacy Study of Stenting, Paclitaxel Eluting Balloon or Atherectomy to Treat Peripheral Artery Disease Unknown status NCT00986752 Phase 4
34 A Multicenter, Therapeutic Used Study to Evaluate the Efficacy and Safety of Pletaal SR Capsule (Cilostazol) in Subjects With Peripheral Arterial Disease Symptom Due to Chronic Occlusive Arterial Disease Unknown status NCT01711333 Phase 4 Pletaal SR capsule
35 Residual Platelet Activity In Advanced Peripheral Artery Disease Unknown status NCT01627431 Phase 4 Acetylsalicylic acid;Clopidogrel
36 Periodontal Therapy in Coronary Artery Patients Unknown status NCT01609725 Phase 4
37 Platelets Induced Vasodilation, in Vitro and in Vivo Study Unknown status NCT00152646 Phase 4 placebo, aspirine, clopidogrel
38 Safety and Efficacy of Low-dose Ticagrelor in Chinese Patients With Stable Coronary Artery Disease Unknown status NCT02514642 Phase 4 low-dose ticagrelor;Clopidogrel
39 Efficacy and Safety of Different Dose of Tirofiban in Interventional Treatment of Complex Coronary Artery Disease Unknown status NCT02294994 Phase 4 tirofiban
40 In Vitro and In Vivo Comparison Between Intravascular Ultrasound (IVUS) Systems Unknown status NCT02154295 Phase 4
41 Pharmacodynamic Comparison of Rosuvastatin Versus Atorvastatin on Platelet Reactivity in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With New P2Y12 Inhibitors (Trial gRANADa) Unknown status NCT02030054 Phase 4 Atorvastatin;Rosuvastatin
42 "Pharmacodynamic Comparison of Omeprazole Versus Pantoprazole on Platelet Reactivity in Patients With Acute Coronary Syndromes on Dual Antiplatelet Therapy With New P2Y12 Inhibitors" -Trial dOPPLER- Unknown status NCT02028234 Phase 4 Pantoprazole,;Omeprazole
43 Potential Impact of Cigarette Smoking on Platelet Reactivity in Patients on Dual Antiplatelet Therapy With P2Y12 Inhibitors Unknown status NCT02026713 Phase 4
44 The Effects of Omega 3 and Vitamin E Supplementation on the Serum Antioxidant Enzymes and Gene Expressions of PGC-1a, h TERT, FOXOs and SIRTs in CAD Patients Unknown status NCT02011906 Phase 4
45 Italian Diffuse/Multivessel Disease ABSORB Prospective Registry: IT-Disappears Unknown status NCT02004730 Phase 4
46 Low-dose Statins and Nutraceuticals in High-intensity Statin-intolerant Patients Unknown status NCT02001883 Phase 4 Association low-dose statin and nutraceuticals
47 Intravascular ULTrasound Guided Versus Conventional Angiography Guided Strategy to Deploy Zotarolimus and Everolimus Eluting Third Generation Stents in the Long Coronary Artery Lesions: ULTRA-ZET Trial Unknown status NCT01979744 Phase 4
48 Randomized Trial of Creatine-kinase Leak After Rosuvastatin At the Time of Percutaneous Coronary Intervention Unknown status NCT01968577 Phase 4 Rosuvastatin
49 Efficacy and Safety of Paclitaxel-eluting Balloon for Treatment of Lesions in Native Small Coronary Arteries Unknown status NCT01903902 Phase 4
50 A Trial to Evaluate Efficacy of Heart-protecting Musk Pill Unknown status NCT01897805 Phase 4 Heart-protecting Musk Pill;Placebo

Search NIH Clinical Center for Arteriosclerosis

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: arteriosclerosis

Genetic Tests for Arteriosclerosis

Anatomical Context for Arteriosclerosis

MalaCards organs/tissues related to Arteriosclerosis:

39
Heart, Endothelial, Testes, Bone, Kidney, Bone Marrow, Monocytes

Publications for Arteriosclerosis

Articles related to Arteriosclerosis:

(show top 50) (show all 1033)
id Title Authors Year
1
Joint position statement on "Nutraceuticals for the treatment of hypercholesterolemia" of the Italian Society of Diabetology (SID) and of the Italian Society for the Study of Arteriosclerosis (SISA). ( 27956024 )
2017
2
Consensus document on the management of the atherogenic dyslipidaemia of the Spanish Society of Arteriosclerosis. ( 28185675 )
2017
3
Mir-22-3p Inhibits Arterial Smooth Muscle Cell Proliferation and Migration and Neointimal Hyperplasia by Targeting HMGB1 in Arteriosclerosis Obliterans. ( 28848136 )
2017
4
Commonalities Between Vasculature and Bone: An Osseocentric View of Arteriosclerosis. ( 28115412 )
2017
5
The Association between Polymorphism of CARD8 rs2043211 and Susceptibility to Arteriosclerosis Obliterans in Chinese Han Male Population. ( 28135700 )
2017
6
Diffuse Carotid Arteriosclerosis and Stroke in a Patient With Schimke Immuno-osseous Dysplasia. ( 28412018 )
2017
7
Blood pressure, heart rate, and double product in a pooled cohort: the Japan Arteriosclerosis Longitudinal Study. ( 28486272 )
2017
8
Vaccine against arteriosclerosis: an update. ( 28515939 )
2017
9
Role of TLR4 and miR-155 in peripheral blood mononuclear cell-mediated inflammatory reaction in coronary slow flow and coronary arteriosclerosis patients. ( 28407320 )
2017
10
Intima-Media Thickness in the Carotid and Femoral Arteries for Detection of Arteriosclerosis in Human Immunodeficiency Virus-Positive Individuals. ( 28146208 )
2017
11
Decalogue of the Spanish Society of Arteriosclerosis to reduce therapeutic inertia. ( 28844490 )
2017
12
Association of arteriosclerosis and/or atherosclerosis with hypertensive target organ damage in the community-dwelling elderly Chinese: the Northern Shanghai Study. ( 28652715 )
2017
13
Sarcopenia and physical function are associated with inflammation and arteriosclerosis in community-dwelling people: The Yakumo study. ( 28741974 )
2017
14
The critical role of SENP1-mediated GATA2 deSUMOylation in promoting endothelial activation in graft arteriosclerosis. ( 28569748 )
2017
15
Monckeberg Arteriosclerosis: AA TelltaleA Sign. ( 28499804 )
2017
16
Difference in bilateral digital volume pulse as a novel non-invasive approach to assessing arteriosclerosis in aged and diabetic subjects: A preliminary study. ( 28467197 )
2017
17
Effect of sirolimus on arteriosclerosis induced by advanced glycation end products via inhibition of the ILK/mTOR pathway in kidney transplantation recipients. ( 28669853 )
2017
18
Arteriosclerosis, Thrombosis, and Vascular Biology. ( 28062452 )
2017
19
WITHDRAWN: What exactly, regression of atherosclerosis or foreign body reaction with hyaline arteriosclerosis, drives transient scaffolding of coronary arteries? A pooled analysis of observational ABSORB studies with a serial multimodality imaging substudy of ABSORB cohort B1 trial. ( 28629625 )
2017
20
Radiographic manifestations of MAPnckeberg arteriosclerosis in the head and neck region. ( 27051640 )
2016
21
MicroRNA-155 Promotes the Directional Migration of Resident Smooth Muscle Progenitor Cells by Regulating Monocyte Chemoattractant Protein 1 in Transplant Arteriosclerosis. ( 27079875 )
2016
22
APOL1 Risk Alleles are Associated with More Severe Arteriosclerosis in Renal Resistance Vessels with Aging and Hypertension. ( 27610422 )
2016
23
Renal artery bilateral arteriosclerosis cause of resistant hypertension in hemodialysed patients. ( 27516040 )
2016
24
Subclinical arteriosclerosis and osteoprotegerin levels in a population with systemic lupus erythematous in the south of Europe. ( 26768749 )
2016
25
TRANSPLANT ARTERIOSCLEROSIS. ( 27495767 )
2016
26
A20 Haploinsufficiency Aggravates Transplant Arteriosclerosis in Mouse Vascular Allografts: Implications for Clinical Transplantation. ( 27495763 )
2016
27
Relationship Of Visceral Fat Accumulation And Arteriosclerosis Risk In Obese Children: 3573 Board #12 June 4, 8: 00 AM - 9: 30 AM. ( 27361939 )
2016
28
Lipoprotein binding to anionic biopolyelectrolytes and the effect of glucose on nanoplaque formation in arteriosclerosis and Alzheimer's disease. ( 26969281 )
2016
29
A Rare Complication of Spinal Cord Ischemia Following Endovascular Aneurysm Repair of an Infrarenal Abdominal Aortic Aneurysm with Arteriosclerosis Obliterans: Report of a Case. ( 27738476 )
2016
30
Arteriosclerosis in the ventral aorta and epicarditis in the bulbus arteriosus of Atlantic salmon (Salmo salar L). ( 27723105 )
2016
31
In Vivo Development of Transplant Arteriosclerosis in Humanized Mice Reflects Alloantigen Recognition and Peripheral Treg Phenotype of Lung Transplant Recipients. ( 27273729 )
2016
32
Development of an earlobe crease identification system to support diagnosis of arteriosclerosis. ( 28268802 )
2016
33
Men, testosterone, and arteriosclerosis. ( 28039222 )
2016
34
Lycopene Ameliorates Transplant Arteriosclerosis in Vascular Allograft Transplantation by Regulating the NO/cGMP Pathways and Rho-Associated Kinases Expression. ( 28050227 )
2016
35
Emerging Novel Biomarkers for Arteriosclerosis Obliterans. ( 26632166 )
2016
36
Baseline Characterization of Japanese Peripheral Arterial Disease Patientsa88- Analysis of Surveillance of Cardiovascular Events in Antiplatelet-Treated Arteriosclerosis Obliterans Patients in Japan (SEASON). ( 26841805 )
2016
37
Prolyl-hydroxylase inhibitor activating hypoxia-inducible transcription factors reduce levels of transplant arteriosclerosis in a murine aortic allograft model. ( 26819270 )
2016
38
Estimating the extent of subclinical arteriosclerosis of persons with prediabetes and diabetes mellitus among Japanese urban workers and their families: a cross-sectional study. ( 26911293 )
2016
39
Beraprost Sodium Protects Against Diabetic Nephropathy in Patients with Arteriosclerosis Obliterans: A Prospective, Randomized, Open-label Study. ( 25959199 )
2015
40
The CHADS2 score is a useful predictor of coronary arteriosclerosis on 320 slice CT and may correlate with prognosis in subjects with atrial fibrillation. ( 25464421 )
2015
41
Work-Related Psychosocial Hazards and Arteriosclerosis. ( 26549394 )
2015
42
Does arteriosclerosis contribute to hemifacial spasm? ( 26545931 )
2015
43
Angina Pectoris and Arteriosclerosis. ( 26547477 )
2015
44
MicroRNA-133a in the Development of Arteriosclerosis Obliterans. ( 25740337 )
2015
45
Advanced glycation end products accelerate arteriosclerosis after renal transplantation through the AGE/RAGE/ILK pathway. ( 26210487 )
2015
46
Non-healing ulcer of right foot due to Monckeberg's arteriosclerosis. ( 25630335 )
2015
47
Alloantibodies and Allograft Arteriosclerosis: Accelerated Adversity Ahead? ( 26271536 )
2015
48
Utility of the Japan arteriosclerosis longitudinal study score for identifying a high risk for vasospastic angina. ( 25876567 )
2015
49
Telomere length, cardiovascular risk and arteriosclerosis in human kidneys: an observational cohort study. ( 26539975 )
2015
50
Relationship Between Lymphedema and Arteriosclerosis: Higher Cardio-Ankle Vascular Index (CAVI) in Lymphedematous Limbs. ( 25695448 )
2015

Variations for Arteriosclerosis

Expression for Arteriosclerosis

Search GEO for disease gene expression data for Arteriosclerosis.

Pathways for Arteriosclerosis

GO Terms for Arteriosclerosis

Cellular components related to Arteriosclerosis according to GeneCards Suite gene sharing:

(show all 13)
id Name GO ID Score Top Affiliating Genes
1 early endosome GO:0005769 9.89 APOA1 APOB APOE HSPD1 VCAM1
2 extracellular region GO:0005576 9.77 ADIPOQ APOA1 APOB APOE CCL2 CRP
3 high-density lipoprotein particle GO:0034364 9.65 APOA1 APOE PON1
4 very-low-density lipoprotein particle GO:0034361 9.63 APOA1 APOB APOE
5 endocytic vesicle lumen GO:0071682 9.58 APOA1 APOB APOE
6 low-density lipoprotein particle GO:0034362 9.54 APOA1 APOB APOE
7 spherical high-density lipoprotein particle GO:0034366 9.52 APOA1 PON1
8 chylomicron GO:0042627 9.5 APOA1 APOB APOE
9 extracellular space GO:0005615 9.5 ADIPOQ APOA1 APOB APOE CCL2 CRP
10 extracellular matrix GO:0031012 9.46 APOE HSPD1 MGP SERPINE1
11 intermediate-density lipoprotein particle GO:0034363 9.43 APOA1 APOB APOE
12 discoidal high-density lipoprotein particle GO:0034365 9.21 APOA1
13 extracellular exosome GO:0070062 10.21 ADIPOQ APOA1 APOB APOE CRP HSPD1

Biological processes related to Arteriosclerosis according to GeneCards Suite gene sharing:

(show top 50) (show all 65)
id Name GO ID Score Top Affiliating Genes
1 extracellular matrix organization GO:0030198 9.96 ELN ICAM1 SERPINE1 SPP1 VCAM1
2 response to lipopolysaccharide GO:0032496 9.95 APOB CCL2 EDN1 ICAM1 VCAM1
3 response to organic substance GO:0010033 9.91 APOB PPARG SPP1
4 steroid metabolic process GO:0008202 9.91 APOA1 APOB APOE HMGCR
5 regulation of lipid metabolic process GO:0019216 9.9 APOA1 HMGCR PPARG
6 positive regulation of peptidyl-tyrosine phosphorylation GO:0050731 9.9 ADIPOQ HGF ICAM1
7 cellular response to insulin stimulus GO:0032869 9.89 ADIPOQ CCL2 PPARG
8 cellular response to interleukin-1 GO:0071347 9.89 CCL2 EDN1 ICAM1
9 regulation of blood pressure GO:0008217 9.88 EDN1 HMOX1 PPARG
10 cell chemotaxis GO:0060326 9.88 CCL2 HGF VCAM1
11 cellular response to drug GO:0035690 9.88 ADIPOQ CCL2 EDN1
12 cholesterol homeostasis GO:0042632 9.87 APOA1 APOB APOE
13 negative regulation of inflammatory response GO:0050728 9.87 ADIPOQ APOA1 APOE HGF
14 response to estrogen GO:0043627 9.86 APOA1 HMOX1 PPARG
15 retinoid metabolic process GO:0001523 9.85 APOA1 APOB APOE
16 cellular response to interferon-gamma GO:0071346 9.85 CCL2 EDN1 ICAM1
17 positive regulation of smooth muscle cell proliferation GO:0048661 9.85 EDN1 HMGCR HMOX1
18 response to activity GO:0014823 9.83 ADIPOQ CCL2 EDN1
19 response to nicotine GO:0035094 9.82 EDN1 HMOX1 VCAM1
20 negative regulation of MAP kinase activity GO:0043407 9.82 ADIPOQ APOE HMGCR
21 response to amino acid GO:0043200 9.8 CCL2 EDN1 ICAM1
22 cellular response to tumor necrosis factor GO:0071356 9.8 APOB CCL2 EDN1 ICAM1 VCAM1
23 negative regulation of smooth muscle cell proliferation GO:0048662 9.79 ADIPOQ HMOX1 PPARG
24 low-density lipoprotein particle clearance GO:0034383 9.77 ADIPOQ APOB HMOX1
25 triglyceride catabolic process GO:0019433 9.77 APOA1 APOB APOE
26 response to ethanol GO:0045471 9.77 ADIPOQ CCL2 HMGCR ICAM1 VCAM1
27 cholesterol efflux GO:0033344 9.76 APOA1 APOB APOE
28 animal organ regeneration GO:0031100 9.76 APOA1 CCL2 HGF PPARG
29 lipoprotein metabolic process GO:0042157 9.75 APOA1 APOB APOE
30 fatty acid oxidation GO:0019395 9.74 ADIPOQ PPARG
31 negative regulation of wound healing GO:0061045 9.73 HMGCR SERPINE1
32 negative regulation of smooth muscle cell migration GO:0014912 9.73 ADIPOQ SERPINE1
33 high-density lipoprotein particle assembly GO:0034380 9.73 APOA1 APOE
34 low-density lipoprotein particle remodeling GO:0034374 9.72 APOB APOE
35 phospholipid efflux GO:0033700 9.72 APOA1 APOE
36 long-chain fatty acid transport GO:0015909 9.72 APOE PPARG
37 negative regulation of hormone secretion GO:0046888 9.72 ADIPOQ EDN1
38 negative regulation of heterotypic cell-cell adhesion GO:0034115 9.71 ADIPOQ APOA1
39 positive regulation of cholesterol efflux GO:0010875 9.71 ADIPOQ APOE PON1
40 maternal process involved in parturition GO:0060137 9.7 CCL2 EDN1
41 chronic inflammatory response GO:0002544 9.7 CCL2 VCAM1
42 positive regulation of cholesterol esterification GO:0010873 9.7 APOA1 APOE
43 high-density lipoprotein particle clearance GO:0034384 9.69 APOA1 APOE
44 negative regulation of macrophage derived foam cell differentiation GO:0010745 9.69 ADIPOQ CRP PPARG
45 chylomicron remnant clearance GO:0034382 9.68 APOB APOE
46 neuron projection regeneration GO:0031102 9.68 APOA1 APOE
47 regulation of Cdc42 protein signal transduction GO:0032489 9.67 APOA1 APOE
48 negative regulation of cellular protein metabolic process GO:0032269 9.67 APOE EDN1
49 negative regulation of blood coagulation GO:0030195 9.67 APOE EDN1 SERPINE1
50 positive regulation of cellular extravasation GO:0002693 9.66 CCL2 ICAM1

Molecular functions related to Arteriosclerosis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.76 ADIPOQ CCL2 EDN1 SPP1
2 phospholipid binding GO:0005543 9.46 APOA1 APOB APOE PON1
3 high-density lipoprotein particle binding GO:0008035 9.43 APOA1 HSPD1
4 lipid transporter activity GO:0005319 9.43 APOA1 APOB APOE
5 lipoprotein particle binding GO:0071813 9.4 APOA1 APOE
6 phosphatidylcholine-sterol O-acyltransferase activator activity GO:0060228 9.37 APOA1 APOE
7 low-density lipoprotein particle receptor binding GO:0050750 9.13 APOB APOE CRP
8 cholesterol transporter activity GO:0017127 8.8 APOA1 APOB APOE
9 protein binding GO:0005515 10.25 ADIPOQ APOA1 APOB APOE COG2 CRP

Sources for Arteriosclerosis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....